Musty odor in containers brings Tylenol 8-Hour recall

A Tylenol recall is the latest shame for McNeil Consumer Healthcare, a subsidiary of Johnson and Johnson. Monday’s announcement marks the fifth time this year the company has been forced to respond drastically to consumer grievances, and comes when the drug maker is under congressional investigation for negligent level of quality manage practices. A pattern of consumer grievances describing a moldy odor within the containers led to the current Tylenol recall. Article resource – New Tylenol recall fifth in a year for Johnson and Johnson by Personal Money Store.

The recall signifies returning any 8-hour Tylenol

The Tylenol recall had been talked about Monday. That was the latest news on it. 128,000 bottles of 50-count Tylenol 8-Hour Caplets were taken back voluntarily by Johnson and Johnson’s McNeil Consumer Healthcare division. Based on the New York Times, the recall had been started by McNeil due to a “musty or moldy odor” within the Tylenol 8-Hour. This had been a complaint with United States and Puerto Rico products. Before March, when the Fort Washington, PA, plant had been closed, it made the batch of Tylenol the company is now recalling. A McNeil spokesperson said the musty odor had been likely caused by contamination from a chemical used to treat wooden transport pallets that leached to the Tylenol — the very same trigger of Tylenol recalls in January, June and July of products created at a McNeil facility in Puerto Rico.

Continued recalls from Tylenol

Several recalls this year by the Johnson and Johnson subsidiary prompted a Congressional inquiry. In November of this past year, five lots of 100-count Tylenol for Arthritis Pain were recalled. They were causing nausea, stomach pain, vomiting and diarrhea to those who took them. In Dec, the Tylenol recall had been expanded to all lots of the product. Tylenol and Motrin were both part of another recall that expanded this that happened in January. Odor complaints and nausea were what caused this recall to happen. In May, 50 children’s medicines were recalled due to quality control and safety concerns.

Ensuring you control plants better

In April, Johnson and Johnson closed the McNeil plant. According to Reuters, Johnson and Johnson is revamping all of the level of quality manage plans in the plant. This is so the violations found by the United States Food and drug administration can be fixed. The FDA found thick dust, grime and contaminated drug ingredients. Johnson and Johnson’s bottom line got about $650 million a year just from the drugs manufactured at the Fort Washington plant. According to Bloomberg, the recalls and facility closings will cost the company a lot. In fact, $600 billion could be lost this year due to it.

Citations

New York Times

prescriptions.blogs.nytimes.com/2010/10/18/more-trouble-with-tylenol/?partner=rss and emc=rss

CNN

cnn.com/2010/HEALTH/10/19/tylenol.recall/index.html?npt=NP1

Reuters

reuters.com/article/idUSTRE69I2W320101019